Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ETS2 pseudogene 1 (ETS2P1) is a noncoding DNA sequence located on the X chromosome that closely resembles the functional ETS2 gene but contains mutations that prevent it from producing a functional protein[1][3]. Pseudogenes, such as ETS2P1, arise from gene duplication or retrotransposition and typically do not serve as direct therapeutic targets because they are unable to encode proteins or perform biological actions[3]. Although most pseudogenes are regarded as nonfunctional, a small number can exert regulatory effects in certain contexts, but there is no known evidence that ETS2P1 plays such a role[3]. Key point: ETS2P1 is a pseudogene and not a therapeutically relevant target, nor does it encode a functional protein. All relevant therapeutic functions and disease associations pertain to the canonical ETS2 gene, not the pseudogene[1][3][4].
None (no mechanisms of drug action apply to pseudogenes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ETS2 pseudogene 1 (ETS2P1).